Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Carlos Javier Alméciga-Díaz"'
Autor:
Sara M. Villada-Troncoso, Jenny Andrea Arévalo-Romero, Vanessa Hernández Rivera, Martha Pedraza-Escalona, Sonia M. Pérez-Tapia, Angela Johana Espejo-Mojica, Carlos Javier Alméciga-Díaz
Publikováno v:
Pharmaceuticals, Vol 17, Iss 9, p 1240 (2024)
Background/Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, was declared a public health emergency in early 2020. The infection initiates when the receptor-binding domain (RBD) of the viral sp
Externí odkaz:
https://doaj.org/article/b298ba00209b4930a989fdaefdfc0116
Autor:
Jenny Andrea Arevalo-Romero, Sandra M. Chingaté-López, Bernardo Armando Camacho, Carlos Javier Alméciga-Díaz, Cesar A. Ramirez-Segura
Publikováno v:
Heliyon, Vol 10, Iss 5, Pp e26423- (2024)
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and MERS in recent decades, underscoring their high potential of infectivity in humans
Externí odkaz:
https://doaj.org/article/e9ae094f206b4d5c901d4cd4bf563ed6
Autor:
Andrés Felipe Leal, Betul Celik, Nidhi Fnu, Shaukat Khan, Shunji Tomatsu, Carlos Javier Alméciga-Díaz
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 31, Iss , Pp 101153- (2023)
Mucopolysaccharidosis (MPS) IVA is a lysosomal storage disorder caused by mutations in the GALNS gene that leads to the lysosomal accumulation of keratan sulfate (KS) and chondroitin 6-sulfate, causing skeletal dysplasia and cardiopulmonary complicat
Externí odkaz:
https://doaj.org/article/9316e153218645a08fbd403092ea96b6
Autor:
Andrés Felipe Leal, Javier Cifuentes, Carlos Emilio Torres, Diego Suárez, Valentina Quezada, Saúl Camilo Gómez, Juan C. Cruz, Luis H. Reyes, Angela Johana Espejo-Mojica, Carlos Javier Alméciga-Díaz
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Mucopolysaccharidosis IV A (MPS IVA) is a lysosomal disorder caused by mutations in the GALNS gene. Consequently, the glycosaminoglycans (GAGs) keratan sulfate and chondroitin 6-sulfate accumulate in the lysosomal lumen. Although enzyme repl
Externí odkaz:
https://doaj.org/article/8af59b0a9eb74959808ff49bd147ec5f
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 22, p 16148 (2023)
Mucopolysaccharidosis IVA (MPS IVA) is a rare disorder caused by mutations in the N-acetylgalactosamine-6-sulfate-sulfatase (GALNS) encoding gene. GALNS leads to the lysosomal degradation of the glycosaminoglyccreasans keratan sulfate and chondroitin
Externí odkaz:
https://doaj.org/article/926aeaab8aab4360b156e005306e2b7a
Autor:
Juan Sebastian Quintero Barbosa, Carlos Javier Alméciga-Díaz, Sandra E. Pérez, María Fernanda Gutierrez
Publikováno v:
Vaccines, Vol 11, Iss 7, p 1173 (2023)
Infectious bovine rhinotracheitis (IBR) and bovine meningoencephalitis are caused by Bovine alphaherpesvirus (BoHV) types 1 and 5, which seriously threaten the global cattle industry. Vaccination to improve immunity is the most direct and effective m
Externí odkaz:
https://doaj.org/article/439b07e9448741b9a67ffc0751e40510
Autor:
Eliana Benincore-Flórez, Jorge El-Azaz, Gabriela Alejandra Solarte, Alexander Rodríguez, Luis H. Reyes, Carlos Javier Alméciga-Díaz, Carolina Cardona-Ramírez
Publikováno v:
Heliyon, Vol 8, Iss 3, Pp e09031- (2022)
Background: Mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, is a rare X-linked recessive disease caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS), which activates intracellular accumulation of nonmetab
Externí odkaz:
https://doaj.org/article/2812baf2325d47e48b41520ab1e921c6
Autor:
Andrés Felipe Leal, Eliana Benincore-Flórez, Estera Rintz, Angélica María Herreño-Pachón, Betul Celik, Yasuhiko Ago, Carlos Javier Alméciga-Díaz, Shunji Tomatsu
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 477 (2022)
Mucopolysaccharidoses (MPSs) constitute a heterogeneous group of lysosomal storage disorders characterized by the lysosomal accumulation of glycosaminoglycans (GAGs). Although lysosomal dysfunction is mainly affected, several cellular organelles such
Externí odkaz:
https://doaj.org/article/9e76a49bcb9b4ab6ae0434ec0473e216
Autor:
Andrés Felipe Leal, Javier Cifuentes, Valentina Quezada, Eliana Benincore-Flórez, Juan Carlos Cruz, Luis Humberto Reyes, Angela Johana Espejo-Mojica, Carlos Javier Alméciga-Díaz
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 18, p 10672 (2022)
The gangliosidoses GM2 are a group of pathologies mainly affecting the central nervous system due to the impaired GM2 ganglioside degradation inside the lysosome. Under physiological conditions, GM2 ganglioside is catabolized by the β-hexosaminidase
Externí odkaz:
https://doaj.org/article/0fd634efe2bf484eae27400e11735bfb
Autor:
Andrés Felipe Leal, Eliana Benincore-Flórez, Daniela Solano-Galarza, Rafael Guillermo Garzón Jaramillo, Olga Yaneth Echeverri-Peña, Diego A. Suarez, Carlos Javier Alméciga-Díaz, Angela Johana Espejo-Mojica
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 17, p 6213 (2020)
GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside accumulation into the lysosome due to mutations on the genes encoding for the β-hexosaminidases subunits or the GM2 activator protein. Three GM2 gangliosidoses have been
Externí odkaz:
https://doaj.org/article/c8f206a2c4034157812f5589fe06d2d5